Related Experiment Video

Updated: Mar 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

[Efficacy and Safety of Rosuvastatin in Patients of Different Risk Groups of Developing Cardiovascular]

O M Drapkina1, S O Eliashevich1

  • 1I.M. Sechenov First Moscow Medical State University, 8, build. 2, Trubetskaya str., 119992 Moscow, Russia.

Kardiologiia
|March 16, 2017
PubMed

Insights

Rosuvastatin demonstrates superior efficacy and safety in preventing cardiovascular events. A bioequivalent generic, Mertenil, offers comparable therapeutic benefits across all patient risk groups.

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Statins are crucial for managing cardiovascular disease (CVD) risk.
  • Rosuvastatin exhibits both lipid-lowering and beneficial pleiotropic effects.
  • Evaluating statin efficacy in primary/secondary CVD prevention and acute coronary syndrome is vital.

Purpose:

  • To review randomized clinical trials on rosuvastatin's efficacy and safety.
  • To compare rosuvastatin with other statins for cardiovascular event prevention.
  • To assess the therapeutic equivalence of Mertenil, a rosuvastatin bioequivalent.

Summary:

  • Rosuvastatin showed the best performance in primary and secondary prevention of cardiovascular events.
  • Mertenil, a bioequivalent generic, demonstrated therapeutic equivalence to original rosuvastatin.
  • Mertenil is effective and safe for cardiovascular complication prevention in all risk categories.

Impact:

  • Rosuvastatin is a leading statin for cardiovascular risk reduction.
  • Mertenil provides a cost-effective, therapeutically equivalent option for patients.
  • Evidence supports Mertenil's use in diverse patient populations for CVD prevention.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
538
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
354
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
786
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
283